Discover the full directors' dealings record of innoscripta SE, a listed equity based in Germany. Shares are quoted on DE DE, under the oversight of BaFin. Operating in the Technology sector, innoscripta SE has recorded 1 public disclosures. Market capitalisation: €915m. The latest transaction was disclosed on 21 June 2025 — Buy. Among the most active insiders: Meyer Beteiligungs-UG (haftungsbeschränkt). The full history is openly available.
1 of 1 declaration
Geographically, innoscripta remains strongly anchored in its home market of Germany while expanding internationally. The group has established offices in Austria, Cologne and Istanbul, and in 2026 it announced new offices in France near Toulouse and in the United States, with additional UK development also highlighted. This expansion is designed to capture growing demand for R&D incentives across OECD markets, where tax-based support mechanisms and documentation requirements are becoming increasingly important. Recent corporate milestones include its IPO and first trading day on May 23, 2025 in the Scale segment, the legal conversion into innoscripta SE, and management’s stated push for further international growth. For investors, the equity story combines software scalability, regulatory tailwinds and an expanding geographic footprint, while remaining exposed to changes in subsidy frameworks and market adoption of R&D compliance tools.